| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. | Chief Medical Officer | Common Stock | 55,311 | $1,469,060 | $26.56 | 25 Sep 2025 | Direct |
| Sionna Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 39,919 | 06 Feb 2025 | Direct | ||
| Sionna Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 19,959 | 12 Jun 2025 | Direct | ||
| Upstream Bio, Inc. | Director | Stock Option (Right to Buy) | 17,096 | 10 Jun 2025 | Direct | ||
| Tectonic Therapeutic, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 9,750 | 25 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TECX | Tectonic Therapeutic, Inc. | 25 Sep 2025 | 2 | $0 | 4 | Chief Medical Officer | 29 Sep 2025, 17:00 |
| SION | Sionna Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 17:07 |
| UPB | Upstream Bio, Inc. | 10 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:17 |
| SION | Sionna Therapeutics, Inc. | 06 Feb 2025 | 1 | $0 | 4 | Director | 10 Feb 2025, 16:05 |
| SION | Sionna Therapeutics, Inc. | 06 Feb 2025 | 0 | $0 | 3 | Director | 06 Feb 2025, 21:15 |
| TECX | Tectonic Therapeutic, Inc. | 04 Feb 2025 | 2 | $0 | 4 | Chief Medical Officer | 06 Feb 2025, 16:05 |
| UPB | Upstream Bio, Inc. | 10 Oct 2024 | 1 | $0 | 4 | Director | 15 Oct 2024, 16:15 |
| UPB | Upstream Bio, Inc. | 10 Oct 2024 | 0 | $0 | 3 | Director | 10 Oct 2024, 20:14 |
| TECX | Tectonic Therapeutic, Inc. | 20 Jun 2024 | 4 | $0 | 4 | Chief Medical Officer | 24 Jun 2024, 16:22 |
| TECX | Tectonic Therapeutic, Inc. | 20 Jun 2024 | 0 | $0 | 3 | Chief Medical Officer | 24 Jun 2024, 16:21 |